Global Registry
A4D-Ab
Nimotuzumab
A4DAB179
|
Cancer
|
Approved
Target
EGFR/ERBB1/HER1
Isotype / Subclass
G1 / IgG1
Clinical Status
Approved
Format
Whole mAb
Synonyms
DE-766
DE766
DE 766
KI-0501
KI0501
KI 0501
KI-501
KI 501
KI501
KI-0502
KI0502
KI 0502
KI-502
KI502
KI 502
OSAG101
OSAG-101
OSAG 101
Taixinsheng
TheraCIM
Theraloc
VECTHIX
Company
Biocon Biopharmaceuticals
Biotech Pharmaceutical
Center of Molecular Immunology
CIMYM
Daiichi Sankyo Inc
Eurofarma
Gilead Sciences
Innogene Kalbiotech
InnoMab
Kuhnil Pharmaceutical Company
Laboratorios Pisa
Oncoscience
+6 more
pH Formulation
—
IMGT
PubChem
Thera-SAbDab
YAbS
Avg A4D Score
-0.7451
Score Range
-0.75
Structures
1
Show Structure Profiles
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity
Associated Structural Profiles
Level 2
Export CSV
Column Filters
Min Seq. Identity (%)
0
Min Avg A4D Score
-5.0
Max Avg A4D Score
2.0
Min pH (min agg. prop.)
0.0
Max pH (max agg. prop.)
14.0
Reset Filters
Structure ID
Source PDB
Seq. Identity
Avg. A4D Score
pH (Min Agg.)
pH (Max Agg.)
Score CDR
Score non-CDR
A4DAB179_3gkw_H_L
3gkw
100%
-0.7451
6.5
4.0
-0.5245
-0.7801